Paylocity Holding Corp header image

Paylocity Holding Corp

PCTY

Equity

ISIN null / Valor 23606709

NASDAQ (2025-12-29)
USD 153.82+0.11%

Paylocity Holding Corp
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Paylocity Holding Corp is a cloud-based provider of payroll and human capital management software solutions for businesses of all sizes.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (13.11.2025):

Paylocity Holding Corp reported its fourth quarter 2025 and full fiscal year 2025 financial results with notable growth across key metrics. In Q4 2025, the company achieved recurring and other revenue of $369.9 million and total revenue of $400.7 million, reflecting a year-over-year increase of 14% and 12% respectively. For the full fiscal year 2025, recurring revenue reached $1,471.8 million and total revenue $1,595.2 million, growing by 15% and 14%. The report also highlighted improving net income, robust adjusted EBITDA performance, significant share repurchase activity, and the strategic launch of Paylocity for Finance to expand its market reach.

Revenue Growth

For Q4 2025, total revenue climbed to $400.7 million and recurring revenue to $369.9 million, marking double-digit year-over-year gains. FY 2025 figures continued this trend with total revenue at $1,595.2 million and recurring revenue at $1,471.8 million, underscoring healthy, sustained top-line expansion.

Profitability & EBITDA

Q4 2025 GAAP net income stood at $48.6 million (approximately $0.86 per share), while FY 2025 GAAP net income increased to $227.1 million. The company saw adjusted EBITDA rise to $583.0 million for FY 2025 and to $130.7 million in Q4, highlighting strong profitability and operational efficiency improvements.

Strategic Initiatives

During FY 2025, Paylocity repurchased 800,000 shares for $150 million and increased its share repurchase authorization by $500 million. Additionally, the launch of Paylocity for Finance marks a strategic expansion into the Office of the CFO, unifying HR and finance operations under one integrated system.

Cash Flow & Balance Sheet Strength

The company ended FY 2025 with robust liquidity, posting cash and cash equivalents of $398.1 million. Operating cash flow reached $418.2 million, while targeted debt repayment supported a solid balance sheet following the Airbase acquisition funding, reinforcing the firm’s financial stability.

Forward Guidance

Looking to fiscal 2026, Paylocity forecasts Q1 recurring revenue between $370.0 million and $375.0 million, with total revenue expected between $397.5 million and $402.5 million. For the full year, recurring revenue guidance is anticipated to be between $1.597 billion and $1.612 billion, and total revenue between $1.707 billion and $1.722 billion, indicating continued growth momentum.

Summarized from source with an LLMView Source

Key figures

-23.0%1Y
-22.2%3Y
-26.1%5Y

Performance

29.9%1Y
35.3%3Y
40.4%5Y

Volatility

Market cap

8365 M

Market cap (USD)

Daily traded volume (Shares)

469,015

Daily traded volume (Shares)

1 day high/low

200.6 / 194.26

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Biomarin Pharmaceutical Inc
Biomarin Pharmaceutical Inc Biomarin Pharmaceutical Inc Valor: 729021
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.15%USD 60.04
Kanzhun Limited
Kanzhun Limited Kanzhun Limited Valor: 111493503
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.24%USD 20.79
Repligen Corp
Repligen Corp Repligen Corp Valor: 965900
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.29%USD 165.73
Concentrix Corporation
Concentrix Corporation Concentrix Corporation Valor: 58052752
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.91%USD 42.34
MKS Instruments Inc
MKS Instruments Inc MKS Instruments Inc Valor: 616689
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.84%USD 162.81
Medpace Holdings Inc
Medpace Holdings Inc Medpace Holdings Inc Valor: 33038552
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.43%USD 569.98
Grifols, SA
Grifols, SA Grifols, SA Valor: 19108728
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.22%USD 9.12
Universal Display Corp
Universal Display Corp Universal Display Corp Valor: 410257
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.30%USD 119.24
ExlService Holdings Inc
ExlService Holdings Inc ExlService Holdings Inc Valor: 2130009
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.07%USD 43.27
Exponent Inc
Exponent Inc Exponent Inc Valor: 861136
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.18%USD 71.22